Dosing is individualised based on body weight, target outcome and the specific tissue or system being addressed
While there is preliminary evidence from clinical trials supporting the potential therapeutic benefits of oral ingestion of BPC-157, more research is needed to fully understand its mechanisms of action and evaluate its safety and efficacy for oral administration in different clinical conditions, including inflammatory bowel disease and and human gastric juices
Effects of low-dose, controlled-release, phentermine plus topiramate combination on weight and associated comorbidities in overweight and obese adults (CONQUER): a randomised, placebo-controlled, phase 3 trial
These shots, which are based on your own blood, are being used more to treat sports injuries and to help wounds heal after surgery
More recently, a growing number of associative and mechanistic studies in neurobehavior, inflammation, neurogenesis, and neurodegeneration have implicated gut-residing microbes as key modulators of several disease etiologies (Soto et al., 2018
